These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6252463

  • 1. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH, Marie PJ, Pettifor JM, Delvin EE.
    N Engl J Med; 1980 Oct 30; 303(18):1023-31. PubMed ID: 6252463
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 30; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 3. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF.
    Am J Dis Child; 1980 Feb 30; 134(2):140-3. PubMed ID: 6243443
    [Abstract] [Full Text] [Related]

  • 4. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE, Glorieux FH.
    Calcif Tissue Int; 1981 Feb 30; 33(2):173-5. PubMed ID: 6260313
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR, Reade TM, DeLuca HF, Hamstra AJ.
    N Engl J Med; 1978 Nov 02; 299(18):976-9. PubMed ID: 308618
    [Abstract] [Full Text] [Related]

  • 9. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun 02; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 10. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC, Lovinger RD, Mamunes P.
    Pediatrics; 1980 Sep 02; 66(3):445-54. PubMed ID: 6893489
    [Abstract] [Full Text] [Related]

  • 11. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
    Saggese G, Baroncelli GI, Bertelloni S, Perri G.
    J Pediatr; 1995 Sep 02; 127(3):395-402. PubMed ID: 7658269
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF.
    N Engl J Med; 1973 Oct 18; 289(16):817-22. PubMed ID: 4357855
    [No Abstract] [Full Text] [Related]

  • 13. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB, Kahler SG.
    South Med J; 1985 Oct 18; 78(10):1179-84. PubMed ID: 2996152
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S, Tieder M, Kohelet D, Liberman OA, Vure E, Bar-Joseph G, Gabizon D, Borochowitz ZU, Varon M, Modai D.
    Clin Endocrinol (Oxf); 1981 Apr 18; 14(4):395-402. PubMed ID: 6266702
    [Abstract] [Full Text] [Related]

  • 16. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
    Beamer WG, Wilson MC, DeLuca HF.
    Endocrinology; 1980 Jun 18; 106(6):1949-55. PubMed ID: 6892799
    [Abstract] [Full Text] [Related]

  • 17. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
    Brickman AS, Coburn JW, Kurokawa K, Bethune JE, Harrison HE, Norman AW.
    N Engl J Med; 1973 Sep 06; 289(10):495-8. PubMed ID: 4353218
    [No Abstract] [Full Text] [Related]

  • 18. [Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus].
    Dumas R, Guermoud C, Garabedian M, Meunier JP.
    Arch Fr Pediatr; 1985 Sep 06; 42(7):507-10. PubMed ID: 3002291
    [Abstract] [Full Text] [Related]

  • 19. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD.
    J Clin Endocrinol Metab; 1992 Dec 06; 75(6):1514-8. PubMed ID: 1464657
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y, Shimotsuji T, Ishii T, Ishida M, Ikehara C, Yamaoka K, Yabuuchi H, Dokoh S.
    Arch Dis Child; 1980 Jan 06; 55(1):49-53. PubMed ID: 6246841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.